Clinical trial
Dichotic Listening as a Predictor of Medication Response in Depression
NCT00296725 · New York State Psychiatric Institute, Other · Completed
Key facts
| NCT number | NCT00296725 |
|---|---|
| Title | Dichotic Listening as a Predictor of Medication Response in Depression |
| Official title | Dichotic Listening as a Predictor of Placebo and Medication Response in Depression |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Major Depression, Dysthymia, Depressive Disorder Not Otherwise Specified |
| Intervention type | Drug |
| Interventions | Fluoxetine, Imipramine |
| Enrollment | 25 |
| Start date | Apr 1, 1994 |
| Primary completion | Jun 1, 2011 |
| Completion | Jun 1, 2011 |
| First posted | Feb 27, 2006 |
| Last update posted | May 30, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: